068760 — Celltrion Pharm Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual balance sheet for Celltrion Pharm, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	29,748	88,161	44,093	32,211	63,480
Net Total Accounts Receivable
Net Total Receivables	142,016	174,008	187,608	222,499	218,500
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	230,954	331,140	311,918	364,831	391,673
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	248,256	241,925	228,243	220,762	222,697
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	548,075	637,884	599,725	641,644	669,462
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	184,927	259,914	211,998	249,346	247,650
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	247,514	305,916	242,938	264,978	272,541
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	300,561	331,969	356,787	376,666	396,922
Total Liabilities & Shareholders' Equity	548,075	637,884	599,725	641,644	669,462
Total Common Shares Outstanding